Consumer durables is a cataloguing of consumer goods that are not essential to be bought very often as they are fashioned in a way so as to last for an extended period of time. Profits in the consumer durables sector were most profoundly…
BMI View: Although we see limited chances for Portugal to improve its competitiveness in order to attract
foreign investment in the near future, rising private consumption and fiscal policy will support
pharmaceutical and healthcare market growth rates over a multi-quarter horizon. In addition, as the
economy continues to recover, the expansion of healthcare coverage will support rising demand for medical
treatment. That said, cost-control measures will translate to marginal pharmaceutical sales growth,
weighing on the market potential appeal for drugmakers.
Headline Expenditure Projections
- Pharmaceuticals: EUR3.44bn (USD3.81bn) in 2015 to EUR3.45bn (USD3.70bn) in 2016; +0.3% in
local currency and -3.2% in US dollar terms. Forecast broadly in line with the last quarter.
- Healthcare: EUR16.71bn (USD18.54bn) in 2015 to EUR16.98bn (USD18.17bn) in 2016; +1.6% in local
currency and -2.0% in US dollar terms. Forecast broadly in line with the last quarter.